Helix and Nebraska Medicine have partnered to launch the Genetic Insights Project, a population genomics program aimed at advancing precision medicine for Nebraskan individuals. Through a single test, the research initiative will assess participants’ genetic predisposition to various cancers and life-threatening diseases, benefiting individual patients and identifying health trends within the region. The project will initially focus on genes linked to breast and ovarian cancer, Lynch syndrome, and high cholesterol, with potential expansion to other conditions. The program aims to enroll 100,000 participants, establishing the largest population health initiative in Nebraska, and is cost-free and voluntary.
What You Should Know:
- Helix, the leading population genomics and viral surveillance company in the nation, and Nebraska Medicine, the state’s largest hospital and leading academic health network, announced a partnership today to launch a population genomics program to drive precision medicine for all individuals in Nebraska called the Genetic Insights Project.
- The research program will identify participants’ risk for a variety of cancers and other potentially life-threatening diseases with a single test, with the goal of not only helping to improve the lives of individual patients but also identifying trends for everyone across the region.
Research-Driven Advancements to Make Precision Medicine More Accessible
“This new genomics program will help patients and their providers understand if they’re genetically predisposed to having an increased risk of one of several significant diseases,” says Allison Cushman-Vokoun, MD, PhD, medical director of Nebraska Medicine’s Molecular Diagnostics and Human Genetics Laboratories. “The Genetic Insights Project is a fundamental step in being able to provide patients with precision care. The project’s large-scale information will also help unlock DNA trends for the entire community—protecting more people from heart-related issues and cancer—for years to come.”
The Genetic Insights Project will provide important information about serious health conditions by testing for mutations in genes connected to a higher risk of breast and ovarian cancer, Lynch syndrome (which is related to colorectal cancer), and high cholesterol. The research program may also expand its panel of genetic markers in the future, potentially providing information about other conditions.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
The goal of the new program is to enroll 100,000 people, which would make it the largest population health program in Nebraska. There will be no cost associated with participating in the research project to any participant involved and participation is completely voluntary. Partnering with Helix allows for the possibility of future genomics testing to be ordered without having to re-sequence patients. This may give providers and patients access to ongoing insights at point-of-care about their health throughout their lifetime.
Source: Hitconsultant